These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35432560)

  • 1. Effects of Jie Yu Wan on Generalized Anxiety Disorder: A Randomized Clinical Trial.
    Li X; Zheng S; Feng S; Ma R; Jia Y; Zhao A; Wei D; Guo H; Duan N; Ding Y; Chen J; Zhu H; Jia H
    Evid Based Complement Alternat Med; 2022; 2022():9951693. PubMed ID: 35432560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of Shu-gan-qing-re formula for generalized anxiety disorder: study protocol for a multi-center, prospective, double-blind, double-dummy, randomized controlled trial.
    Chen P; Zhu H; Ning Y; Yin D; Jia H
    Trials; 2020 Mar; 21(1):266. PubMed ID: 32171323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Jianpi Jieyu Decoction for Patients with Mild-to-Moderate Depression of Xin (Heart)-Pi (Spleen) Deficiency Syndrome: A Multi-centre Randomized Controlled Study.
    Chen X; Chen JX; Han XY; Zhao Y; Cao J; Jiao XZ; Liu HM; Guo CL; Meng S; Liang S; Qi JX; Chen D; Li MX; Jiao YX; Wang TT; Hong X
    Chin J Integr Med; 2023 Apr; 29(4):299-307. PubMed ID: 36301455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative Safety and Efficacy of Two Doses of Tandospirone Citrate for Generalized Anxiety Disorder: A Multicenter Randomized Controlled Trial.
    Li Q; Zhang H; Lin G; Shi S; Zhang Y; Ji J; Yang L; Yao J; Wu W
    Neuropsychiatr Dis Treat; 2022; 18():1653-1664. PubMed ID: 35968511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.
    Katz IR; Reynolds CF; Alexopoulos GS; Hackett D
    J Am Geriatr Soc; 2002 Jan; 50(1):18-25. PubMed ID: 12028242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
    Davidson JR; DuPont RL; Hedges D; Haskins JT
    J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial.
    Sha Z; Hou Y; Xue C; Li O; Li Z; Wang H; Zhang W; Xu J
    Trials; 2020 Jan; 21(1):107. PubMed ID: 31973702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of Shugan granule in the treatment of mixed anxiety-depressive disorder: A multicenter, randomized, double-blind, placebo-controlled trial.
    Li Y; Li L; Guo R; Yu H; Wang X; Wang B; Wang Q; Li Z; Zhao H; Temu Q; Chen X; Zhang Y; An J; Cai X; Li A; Qi L; Shang J; He H; Yang D; Lin J; Zhang Y; Zou T
    J Ethnopharmacol; 2022 May; 290():115032. PubMed ID: 35085742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of group mindfulness-based cognitive therapy and group cognitive behavioural therapy on symptomatic generalized anxiety disorder: a randomized controlled noninferiority trial.
    Jiang SS; Liu XH; Han N; Zhang HJ; Xie WX; Xie ZJ; Lu XY; Zhou XZ; Zhao YQ; Duan AD; Zhao SQ; Zhang ZC; Huang XB
    BMC Psychiatry; 2022 Jul; 22(1):481. PubMed ID: 35854250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability, Tolerability, and Estimates of Putative Treatment Effects of Probiotics as Adjunctive Treatment in Patients With Depression: A Randomized Clinical Trial.
    Nikolova VL; Cleare AJ; Young AH; Stone JM
    JAMA Psychiatry; 2023 Aug; 80(8):842-847. PubMed ID: 37314797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jiawei Xiaoyao capsule treatment for mild to moderate major depression with anxiety symptoms: a randomized, double-blind, double-dummy, controlled, multicenter, parallel-treatment trial.
    Su R; Fan J; Li T; Cao X; Zhou J; Han Z; Ma Y
    J Tradit Chin Med; 2019 Jun; 39(3):410-417. PubMed ID: 32186013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-treatment of buspirone with atypical antipsychotic drugs (AAPDs) improved neurocognitive function in chronic schizophrenia.
    Wang Y; Yang X; Song X; Zhao L; Wei J; Wang J; Tian H; Zheng C; Wei M; Wang Q; Guo W; Deng W; Li T; Ma X
    Schizophr Res; 2019 Jul; 209():135-140. PubMed ID: 31101513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of escitalopram combined with botulinum toxin A in patients with generalized anxiety disorder and comorbid headache.
    Wang Y; Yang X; Ji X; Liu M; Zhou C
    Psychopharmacology (Berl); 2023 Oct; 240(10):2061-2070. PubMed ID: 37481677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early outcomes, associated factors and predictive values of clinical outcomes of tandospirone in generalized anxiety disorder: a post-hoc analysis of a randomized, controlled, multicenter clinical trial.
    Fu Y; Ji JL; Shi SX; Zhang HY; Lin GZ; Zhang YL; Li X; Wu WY
    Curr Med Res Opin; 2023 Apr; 39(4):597-603. PubMed ID: 36842964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
    CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study.
    Wang M; Tong JH; Huang DS; Zhu G; Liang GM; Du H
    Psychopharmacology (Berl); 2014 Jul; 231(14):2811-8. PubMed ID: 24481570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of escitalopram and sertraline in post-stroke depression: a randomized controlled trial.
    Yan N; Hu S
    BMC Psychiatry; 2024 May; 24(1):365. PubMed ID: 38750479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.